When the near-vision eye chart was used as the control test, results with the iPad and projected Landolt ring were consistent 76% of the time in the right eye and 83% of the time in the left eye.

The Food and Drug Administration has given the green light to Vuity 1.25%, the first approved prescription, once-daily eye drops to treat age-related blurry near vision.

MR-141 met primary endpoint with ≥3-line near vision gain at 12 hours post-dose on Day 8 vs. placebo (p<0.0001). No serious adverse events; most common side effects were mild, including eye ...

Lenz Therapeutics, which is developing daily eye drops to improve near vision for middle-aged folks, has raised $83.5 million in venture capital funding. The round, announced last week, brings the ...

Share on Pinterest New eye drops approved by federal regulators could help people with age-related blurry vision. Cucurudza/Getty Images Federal regulators approved the use of Vuity, eye drops ...